PRESS RELEASE published on 03/27/2023 at 08:00, 1 year 6 months ago Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea
PRESS RELEASE published on 03/17/2023 at 08:00, 1 year 7 months ago Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
PRESS RELEASE published on 03/17/2023 at 08:00, 1 year 7 months ago Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR')
PRESS RELEASE published on 03/09/2023 at 08:00, 1 year 7 months ago Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
PRESS RELEASE published on 03/09/2023 at 08:00, 1 year 7 months ago Biophytis présente les résultats positifs de Phase 2-3 COVA à la 21ème Conférence « Lung Science » - ERS 2023
PRESS RELEASE published on 03/02/2023 at 00:00, 1 year 7 months ago Biophytis annonce la signature d’un accord-cadre avec Intsel Chimos, laboratoire pharmaceutique qui exploitera Sarconeos (BIO101) en France pour le traitement des formes sévère de COVID-19
PRESS RELEASE published on 03/02/2023 at 00:00, 1 year 7 months ago Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1
PRESS RELEASE published on 02/27/2023 at 08:00, 1 year 7 months ago Biophytis: Biophytis démarre le processus règlementaire de demande d’autorisation d’accès précoce en France auprès de la Haute Autorité de Santé (HAS) pour le traitement avec Sarconeos (BIO101) des fo
PRESS RELEASE published on 02/27/2023 at 08:00, 1 year 7 months ago Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of
PRESS RELEASE published on 02/23/2023 at 08:00, 1 year 7 months ago : Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023
Published on 10/18/2024 at 15:00, 19 minutes ago Namibia Critical Metals Receives Environmental Clearance Certificate for Mining Activities on its Lofdal Heavy Rare Earth Project
Published on 10/18/2024 at 14:31, 48 minutes ago Vicinity Motor Corp. Receives Notice from RBC of Intent to File Receivership Order on Monday, October 21, 2024
Published on 10/18/2024 at 14:00, 1 hour 19 minutes ago Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions
Published on 10/18/2024 at 14:00, 1 hour 19 minutes ago NXT Energy Solutions to Present at the LD Micro Main Event XVII
Published on 10/18/2024 at 13:00, 2 hours 19 minutes ago Torq Announces USD$1.81 (CAD$2.49) Million Interim Loan Facility from Gold Fields for Santa Cecilia Project
Published on 10/18/2024 at 14:59, 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: StoneX Group Inc.
Published on 10/18/2024 at 14:58, 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 10/18/2024 at 14:55, 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 10/18/2024 at 08:00, 7 hours 19 minutes ago NFL BIOSCIENCES : L’ÉQUIPE DIRIGEANTE PRÉPARE LES PROCHAINES ÉTAPES DU DÉVELOPPEMENT
Published on 10/18/2024 at 08:00, 7 hours 19 minutes ago NFL BIOSCIENCES: LEADERSHIP TEAM PREPARING THE NEXT STAGES IN ITS DEVELOPMENT
Published on 10/17/2024 at 17:45, 21 hours 34 minutes ago COGELEC : Chiffre d’affaires du 3e trimestre 2024 : 17,4 M€ (+ 13,1 %).